Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Assessing the Prognosis of Pulmonary Embolism Using Clinical and Imaging Biomarkers (Retrospective & Prospective )

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Kyongtae Ty Bae, M.D., Ph.D., University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00805246
First received: December 5, 2008
Last updated: October 25, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2017
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)